Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs.
Saved in:
| Title: | Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs. |
|---|---|
| Authors: | Kerr CP, Jin WJ, Oñate AJ, Kwon O, Comas Rojas H, Clark PA, Hyun M, Ferreira CA, Bio Idrissou M, Rahman MM, Wang Y, Sheehan-Klenk J, Chen T, Jagodinsky JC, Nystuen E, Zangl LM, Pinchuk AN, Kim K, Hernandez R, Bednarz BP, Weichert JP, Kastan MB, Gilmer TM, Morris ZS |
| Source: | Radiation research [Radiat Res] 2026 Mar 25; Vol. 205 (5), pp. 459-471. Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Radiation Research Society Country of Publication: United States NLM ID: 0401245 Publication Model: Electronic Cited Medium: Internet ISSN: 1938-5404 (Electronic) Linking ISSN: 00337587 NLM ISO Abbreviation: Radiat Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
